{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:19:23Z","timestamp":1791580763102,"version":"4.3.4"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>\n            Sclerostin is most recognized for its role in controlling bone formation but is also expressed in the heart, aorta, coronary, and peripheral arteries. This review summarizes research on sclerostin\u2019s role in cardiovascular disease. Rodent studies have found sclerostin to be expressed at sites of arterial calcification. In contrast, aortic sclerostin was reported to be downregulated in a mouse model of abdominal aortic aneurysm, and transgenic upregulation or administration of sclerostin was found to prevent abdominal aortic aneurysm and atherosclerosis formation. Sclerostin deficiency was reported to stimulate cardiac rupture in one rodent model. In humans, 7 of 11 studies reported a significant association between high serum sclerostin and high carotid intima media thickness. Ten of 15 studies reported a significant association between high serum sclerostin and severe arterial calcification. Twelve of 14 studies reported a significant association between high serum sclerostin and high arterial stiffness or atherosclerosis severity. Four of 9 studies reported a significant association between high serum sclerostin and high risk of cardiovascular events. A meta-analysis of randomized controlled trials suggested that administration of the sclerostin blocking antibody romosozumab did not significantly increase the risk of major adverse cardiovascular events (risk ratio, 1.14 [95% CI, 0.83\u20131.57];\n            <jats:italic>P<\/jats:italic>\n            =0.54) or cardiovascular death (risk ratio, 0.92 [95% CI, 0.53\u20131.59];\n            <jats:italic>P<\/jats:italic>\n            =0.71). Human genetic studies reported variants predisposing to low arterial sclerostin expression were associated with a high risk of cardiovascular events. Overall, past research suggests a cardiovascular protective role of sclerostin but findings have been inconsistent, possibly due to variations in study design, the unique populations and models studied, and the heterogeneous methods used.\n          <\/jats:p>","DOI":"10.1161\/atvbaha.122.317635","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T09:01:20Z","timestamp":1652346080000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":55,"title":["Role of Sclerostin in Cardiovascular Disease"],"prefix":"10.1161","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5779-8848","authenticated-orcid":true,"given":"Jonathan","family":"Golledge","sequence":"first","affiliation":[{"name":"Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry (J.G., S.T.), James Cook University, Townsville, Queensland, Australia."},{"name":"The Australian Institute of Tropical Health and Medicine J.G.\u201a S.T.), James Cook University, Townsville, Queensland, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0322-6147","authenticated-orcid":true,"given":"Shivshankar","family":"Thanigaimani","sequence":"additional","affiliation":[{"name":"Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry (J.G., S.T.), James Cook University, Townsville, Queensland, Australia."},{"name":"The Australian Institute of Tropical Health and Medicine J.G.\u201a S.T.), James Cook University, Townsville, Queensland, Australia."},{"name":"The Department of Vascular and Endovascular Surgery, Townsville University Hospital, Queensland, Australia (J.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/318811"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.006769"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301716200"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6570"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/8755122520967632"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126467"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20200980"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.05.022"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1139\/apnm-2020-0683"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.64393"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103827"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.116.308723"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019595"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.21054"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M110.001693"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11070428"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24140"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.9630"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-018-0919-y"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00528.2017"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19155-4"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.135re9"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0040115"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1957710"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/mc.21845"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.08320"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605307"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-2033-4"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1604-0"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.194"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4287"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3168"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/5p7mb4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2019.04.012"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.2174\/1567202614666170619080526"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2017.6390"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv077"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1691"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2019.107469"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164113510923"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-019-04878-7"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-018-1935-5"},{"key":"e_1_3_3_44_2","first-page":"302","article-title":"Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients.","volume":"36","author":"Genre F","year":"2018","unstructured":"Genre, F, Rueda-Gotor, J, Remuzgo-Mart\u00ednez, S, Corrales, A, Ubilla, B, Mijares, V, Fern\u00e1ndez-D\u00edaz, C, Portilla, V, Blanco, R, Hern\u00e1ndez, JL, et al. Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients. Clin Exp Rheumatol. 2018;36:302\u2013309.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_3_45_2","first-page":"317","article-title":"Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study.","volume":"22","author":"Koos R","year":"2013","unstructured":"Koos, R, Brandenburg, V, Mahnken, AH, Schneider, R, Dohmen, G, Autschbach, R, Marx, N, Kramann, R. Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study. J Heart Valve Dis. 2013;22:317\u2013325.","journal-title":"J Heart Valve Dis"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-219"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.5414\/CN109333"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.01.010"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2013.05.010"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv081"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-015-3127-9"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2327"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.10.031"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2014.04.002"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1159\/000494441"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3056"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02736-8"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02495-x"},{"key":"e_1_3_3_59_2","first-page":"2816","article-title":"Serum sclerostin as an independent marker of peripheral artery disease in elderly persons.","volume":"11","author":"Teng IC","year":"2018","unstructured":"Teng, IC, Wang, JH, Lee, CJ, Hou, JS, Hsu, BG. Serum sclerostin as an independent marker of peripheral artery disease in elderly persons. Int J Clin Exp Pathol. 2018;11:2816\u20132821.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.11.008"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003300"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_90_18"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0955-5"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfaa069"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050764"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118816661"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2016-0031"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.26442\/terarkh201890648-54"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9595-4"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030186"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.2217\/bmm-2021-0168"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2016.08.003"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01393-2"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1823"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.045"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.014816"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/resp.14048"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079721"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07670712"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12020111"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.3390\/children8090788"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-2989"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3148"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0104"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2186"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.07.021"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab081"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/171674"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1159\/000446278"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2015.150801"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2106"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2018.12.007"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4503"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.11.015"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104697"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab193"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.19.00790"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3622"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3452"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708322"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.07.005"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31613-6"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-02163"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.3283"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.afos.2021.09.002"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.10.005"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.2165\/00129784-200101050-00008"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.18.2217"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATVBAHA.122.317635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:50:39Z","timestamp":1715557839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.122.317635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":108,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1161\/ATVBAHA.122.317635"],"URL":"https:\/\/doi.org\/10.1161\/atvbaha.122.317635","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"2022-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}